View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . May 18th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Breast Cancer - Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients

Pharmaceuticals - RAPAFLO(TM) (silodosin) Provides Rapid and Sustained Benign Prostatic Hyperplasia (BPH) Symptom Relief in as Little as Three Days

Angiology - Research on angiology detailed by scientists at Georgetown University

Brachytherapy - Recent findings from University Hospital highlight research in brachytherapy

Breast Cancer - New breast cancer study findings have been reported by F. Recchia and colleagues

Cardiovascular Disease - New findings from McMaster University in the area of cardiovascular disease described

Combination Therapy - New combination therapy study results reported from Mayo Clinic

Fusion Proteins - Research from Fourth Military Medical University has provided new data on fusion proteins

Magnetic Resonance - Studies from J. Whitehead and co-researchers yield new data on magnetic resonance

Non-Small Cell Lung Cancer - New data from A.M. Traynor et al illuminate research in non-small cell lung cancer

Non-Small Cell Lung Cancer - Study results from Shanghai Jiao Tong University in the area of non-small cell lung cancer published

Pulmonary Hypertension - New pulmonary hypertension study findings have been reported by F. Grimminger and co-researchers

Small Cell Lung Cancer - Data on small cell lung cancer reported by L. Horn and co-researchers

Breast Cancer - Scientists at Washington University, Department of Surgery detail research in breast cancer

Clinical Trial Research - Researchers at University of Iowa target clinical trial research

Life Sciences - Investigators at Medical University of Vienna publish new data on life sciences

Life Sciences - New life sciences findings from Medical University of Vienna described

Lymphoma Therapy - Research from Mayo Clinic provides new data on lymphoma therapy

Menopause - Research on menopause discussed by scientists at Kitasato University, Clinical Investigation Center

Amarin Corporation plc - Amarin Receives Special Protocol Assessment Agreement from the FDA for Phase 3 Cardiovascular Trial

Array BioPharma Inc. - Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2009

Burzynski Research Institute, Inc. - Burzynski Research Institute Announces Positive Results of Phase II ANP Clinical Trial

Cancer - Successful Phase I/II Clinical Trial Results From Cancer Patients Treated With Anti-Cancer Drug From Axelar AB

Central Nervous System Disorders - Cephalon Reports Strong Sales and Earnings for the First Quarter 2009

Chronic Pain - Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain Featured at 2009 American Pain Society Annual Meeting

Clinical Trial Research - Poniard Pharmaceuticals to Present New Data from Phase 2 Clinical Trials of Picoplatin in Multiple Tumor Types at the 45th Annual Meeting of the American Society of Clinical Oncology

Depomed, Inc. - Depomed Reports First Quarter 2009 Financial Results

Diabetes - Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications

Dynavax Technologies Corporation - Dynavax Presents Data From Novel Universal Flu Vaccine Candidate

Endocyte Inc. - Endocyte Initiates Phase 1 Trial of EC0489 for Treatment of Refractory or Metastatic Solid Tumors

Enzon Pharmaceuticals, Inc. - Enzon Reaches Phase II Dose for PEG-SN38

Flu Vaccines - Novavax Announces Enrollment in the Second Phase II Study of its Seasonal Influenza VLP Vaccine Candidate

Genentech, Inc. - FDA Grants Accelerated Approval of Avastin for Brain Cancer Glioblastoma That Has Progressed Following Prior Therapy

Genzyme Corporation - Genzyme Provides Outlook for Long-Term Growth at its Analyst Day Meeting

Influenza - BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results

Inotek Pharmaceuticals - Inotek Pharmaceuticals Presents Preclinical Data in Support of Novel Glaucoma Candidate, INO-8875 at ARVO

Inspire Pharmaceuticals, Inc. - Inspire Initiates Phase 2 Program with AzaSite® for the Treatment of Blepharitis

Knee Replacement - AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System

LifeCycle Pharma A/S - LifeCycle Pharma Announces Positive Interim Results of Phase 2 Clinical Trial of LCP-Tacro for the Prevention of Organ Rejection in De Novo Kidney Transplant Patients

Ligand Pharmaceuticals Incorporated - Ligand Pharmaceuticals Announces First Quarter Results

Macular Degeneration - Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II

Neuropathy - Aegera Initiates Phase 2 Clinical Trial of AEG33773 - a Small Molecule Targeting Neuropathic Pain

Pervasis Therapeutics, Inc. - Pervasis Therapeutics Granted Orphan Drug Designation for Vascugel®

Pharmaceuticals - MAP Pharmaceuticals Reports First Quarter of 2009 Financial Results

Pulmatrix Inc. - Pulmatrix Announces Ph 1b/2a Clinical Trial of Novel iCALM Therapy for Flu

Rexahn Pharmaceuticals, Inc. - Rexahn Reports Positive Preliminary Findings in ZoraxelTM Clinical Trial to Treat Erectile Dysfunction

Small Cell Lung Cancer - Independent Data Monitoring Committee Supports Continuation of Picoplatin Phase 3 SPEAR Registration Trial in Small Cell Lung Cancer

Therapy - Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders

Therapy - Nektar Therapeutics Reports First Quarter 2009 Financial Results

Tranzyme Pharma - Tranzyme Pharma Initiates Dosing in a Phase 2 Study of its Oral Ghrelin Agonist TZP-102 in Patients with Gastroparesis

Tuberculosis - Sequella Commences Phase 1B Study for New Tuberculosis Drug SQ109

Vaccines - Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team

Vascular Endothelial Growth Factor - Positive Results for Ophthotech's Novel Therapy for Wet AMD - Study of Anti-PDGF and Anti-VEGF Therapy Shows Significant Neovascular Regression and Enhanced Visual Outcome

VaxInnate Corporation - VaxInnate Corporation Closes $30 Million Round of Financing; Wellcome Trust Leads Round

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx